Loading company…
Oculotronics develops ophthalmic surgical robots and related medical systems.
Founded in 2020 and based in Guangzhou, China, Oculotronics develops ophthalmic surgical systems, including the Clippard robot for procedures such as vitreoretinal surgery, injections, corneal transplants and cataract surgery. The company reported conducting the world's first 5G remote micron-sized eye surgery on June 23, 2023. In June 2026, it raised nearly CNY 100 million in Series A funding from Essential Capital, Minggui Capital and other investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in